Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mandanol 500mg tablets
0407010H0CGAAAM
|
Mandanol | Paracetamol | Central Nervous System | 159 |
|
Mandanol 500mg caplets
0407010H0CGABAM
|
Mandanol | Paracetamol | Central Nervous System | 149 |
|
Calpol Six Plus Fastmelts 250mg tablets
0407010H0BEAQDC
|
Calpol | Paracetamol | Central Nervous System | 146 |
|
Paracetamol 60mg suppositories
0407010H0AACWCW
|
Paracetamol | Paracetamol | Central Nervous System | 140 |
|
Panadol Advance 500mg tablets
0407010H0BFAJAM
|
Panadol (Systemic) | Paracetamol | Central Nervous System | 69 |
|
Calpol Infant Sugar Free Colour Free 120mg/5ml susp
0407010H0BEATAW
|
Calpol | Paracetamol | Central Nervous System | 68 |
|
Paracetamol 1g/100ml solution for infusion vials
0407010H0AADIDI
|
Paracetamol | Paracetamol | Central Nervous System | 37 |
|
Paracetamol 120mg/5ml oral solution paediatric
0407010H0AAABAB
|
Paracetamol | Paracetamol | Central Nervous System | 31 |
|
Paracetamol 120mg/5ml oral suspension 5ml sachets sugar free
0407010H0AAAJAJ
|
Paracetamol | Paracetamol | Central Nervous System | 29 |
|
Paracetamol 250mg/5ml oral solution
0407010H0AADBDB
|
Paracetamol | Paracetamol | Central Nervous System | 29 |
|
Paracetamol 500mg/5ml oral liquid
0407010H0AACPCP
|
Paracetamol | Paracetamol | Central Nervous System | 22 |
|
Panadol ActiFast 500mg tablets
0407010H0BFAIAM
|
Panadol (Systemic) | Paracetamol | Central Nervous System | 16 |
|
Altridexamol 1000mg effervescent tablets
0407010H0CVAADU
|
Altridexamol | Paracetamol | Central Nervous System | 13 |
|
Paracetamol 80mg suppositories
0407010H0AACHCH
|
Paracetamol | Paracetamol | Central Nervous System | 11 |
|
Alvedon 125mg suppositories
0407010H0CDAACM
|
Alvedon | Paracetamol | Central Nervous System | 8 |
|
Paracetamol 500mg/50ml solution for infusion vials
0407010H0AADKDK
|
Paracetamol | Paracetamol | Central Nervous System | 7 |
|
Parasolve 500mg effervescent tablets
0407010H0CWAADS
|
Parasolve | Paracetamol | Central Nervous System | 7 |
|
Calpol Infant 120mg/5ml susp 5ml sachets sugar free
0407010H0BEADAJ
|
Calpol | Paracetamol | Central Nervous System | 5 |
|
Alvedon 250mg suppositories
0407010H0CDACCB
|
Alvedon | Paracetamol | Central Nervous System | 4 |
|
Calpol Infant Original 120mg/5ml oral suspension
0407010H0BEAAAI
|
Calpol | Paracetamol | Central Nervous System | 4 |
|
Calpol Six Plus 250mg/5ml susp 5ml sachets sugar free
0407010H0BEARDE
|
Calpol | Paracetamol | Central Nervous System | 4 |
|
Paracetamol 120mg/5ml oral suspension 5ml sachets
0407010H0AADJDJ
|
Paracetamol | Paracetamol | Central Nervous System | 3 |
|
SolpaOne 1000mg effervescent tablets
0407010H0CXAADU
|
SolpaOne | Paracetamol | Central Nervous System | 2 |
|
Alvedon 60mg suppositories
0407010H0CDABCW
|
Alvedon | Paracetamol | Central Nervous System | 1 |
|
Boots Paracetamol 500mg caplets
0407010H0B3AFAM
|
Boots Pain Relief (Paracetamol) | Paracetamol | Central Nervous System | 1 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.